3D Medlab

Marle Group entered an agreement to acquire France based 3D MEDLAB. Marle Group now has 7 production facilities exclusively focused on orthopedic implant manufacturing for OEM’s globally. The Marle Group is a strategic partner with a reputation for excellence focused on delivering value to its customers through technical expertise, efficient contract manufacturing and outstanding quality systems.

3D MEDLAB is a pioneer in additive manufacturing in the medical device sector and specializes in engineering, design and development, and production of 3D printed metal implants, polymer implants and components for the ortho, spine, trauma, and cardio markets. 3D MEDLAB works with OEM’s during initial stage prototypes, FDA approvals and large volume production.

The acquisition of 3D MEDLAB expands Marle Group’s contract manufacturing offering with their new additive manufacturing solution that creates a total end-to-end solution. This solution supports research and innovation, product development, prototyping, various manufacturing platforms (additive, forging, casting, or subtractive machining), inspection and quality, complete packaging, and delivery of complex finished product.

Marle Group will continue to make strategic acquisitions and partnerships to expand its value-added portfolio for its OEM customers.

For more information, please visit our LinkedIn profile.